Skip to main content
Top
Published in: Tumor Biology 5/2014

01-05-2014 | Research Article

An analysis of the most-cited research papers on oncology: which journals have they been published in?

Author: Faruk Tas

Published in: Tumor Biology | Issue 5/2014

Login to get access

Abstract

The most-cited papers (MCPs) are likely those that impressed researchers and had profound influence on clinical practice or future developments in the related scientific field. This study was conducted to explore a bibliometric approach to assess where the oncology-related MCPs have been published in. The source of the data presented in this study was provided by using the InCitesTM, Web of Science, Thomson Reuters Database (2013). It contained any journal indexed by ISI between 1979 and 2013. The term MCPs arbitrarily defined as equal or more than 100 citations. A total of 565 publications were cited equal or more than 100 times. They were published in 79 different journals (64 oncology, 12 medicine, and 3 science), led by the Journal of Clinical Oncology (n = 76; 13.5 %) and Cancer Research (n = 66; 11.7 %) followed by Oncogene (n = 46; 8.1 %), Nature Reviews Cancer (n = 41; 7.3 %), and Cancer (n = 37; 6.5 %). Moreover, the journal categories with the MCPs were the Oncology with 495 articles (87.6 %), followed by the Medicine with 60 (10.6 %) articles. However, the numbers of journals related to Science (n = 10; 1.8 %) were the least. The MCPs were cited a total of 118,531 times. The citations ranged from 100 to 1,790, and the median number was 149. The total numbers of MCPs were the most prominent for the journals, the New England Journal of Medicine (median 398), Lancet (median 213), and Nature Reviews Cancer (median 210). In other side, the counts of MCPs were the highest for the Science and Medicine-categorized journals (median 212.5 and 192.5 citations, respectively). The MCPs categorized as Oncology were the least cited (median 145). The median number of MCPs per year was 18.7 with range 4.1–858.5. The annual most valuable MCPs were also published in the journal Nature Reviews Cancer (median 42) and the New England Journal of Medicine (median 38.7). Likewise, the numbers of MCPs were the highest for the Science-categorized journals (median 37), whereas the citations per year were significantly lower in Medicine and Oncology-categorized journals (25.8 and 17.8, respectively). In conclusion, most of the MCPs were published in Oncology specialized journals.
Literature
2.
3.
go back to reference Tasli L, Kacar N, Argenziano G. A scientometric analysis of dermoscopy literature over the past 25 years. J European Acad Dermatol Venereol. 2011;26:1142–8.CrossRef Tasli L, Kacar N, Argenziano G. A scientometric analysis of dermoscopy literature over the past 25 years. J European Acad Dermatol Venereol. 2011;26:1142–8.CrossRef
4.
go back to reference Nieder C, Grosu A, Mehta MP. Brain metastases research 1990–2010: pattern of citation and systematic review of highly cited articles. The Scientific World J 2012; Article ID 721598. Nieder C, Grosu A, Mehta MP. Brain metastases research 1990–2010: pattern of citation and systematic review of highly cited articles. The Scientific World J 2012; Article ID 721598.
5.
go back to reference Paladugu R, Schein M, Gardezi S, Wise L. One hundred citation classics in general surgical journals. World J Surg. 2002;26:1099–105.CrossRefPubMed Paladugu R, Schein M, Gardezi S, Wise L. One hundred citation classics in general surgical journals. World J Surg. 2002;26:1099–105.CrossRefPubMed
6.
go back to reference Ponce FA, Lozano AM. Highly cited works in neurosurgery. Part I: the 100 top-cited papers in neurosurgical journals. J Neurosurg. 2010;112:223–32.CrossRefPubMed Ponce FA, Lozano AM. Highly cited works in neurosurgery. Part I: the 100 top-cited papers in neurosurgical journals. J Neurosurg. 2010;112:223–32.CrossRefPubMed
7.
go back to reference Celayir S, Sander S, Elicevik M, Vural A, Celayir AC. The most commonly cited articles in pediatric surgical journals. Eur J Pediatr Surg. 2008;18:160–3.CrossRefPubMed Celayir S, Sander S, Elicevik M, Vural A, Celayir AC. The most commonly cited articles in pediatric surgical journals. Eur J Pediatr Surg. 2008;18:160–3.CrossRefPubMed
8.
go back to reference Feijoo JF, Limeres J, Fernandez-Varela M, Ramos I, Diz P. The 100 most cited articles in dentistry. Clin Oral Invest 2013, June 15, on line published. Feijoo JF, Limeres J, Fernandez-Varela M, Ramos I, Diz P. The 100 most cited articles in dentistry. Clin Oral Invest 2013, June 15, on line published.
9.
go back to reference Lopez-Illescas C, Moya-Anegon F, Moed HF. The actual citation impact of European oncological research. Eur J Cancer. 2008;44:228–36.CrossRefPubMed Lopez-Illescas C, Moya-Anegon F, Moed HF. The actual citation impact of European oncological research. Eur J Cancer. 2008;44:228–36.CrossRefPubMed
10.
go back to reference Ugolini D, Mela GS. Oncological research overview in the European Union. A 5-year survey. Eur J Cancer. 2003;39:1888–94.CrossRefPubMed Ugolini D, Mela GS. Oncological research overview in the European Union. A 5-year survey. Eur J Cancer. 2003;39:1888–94.CrossRefPubMed
11.
go back to reference Lewison G. The publication of cancer research papers in high impact journals. ASLIB PROC. 2003;55:379–87.CrossRef Lewison G. The publication of cancer research papers in high impact journals. ASLIB PROC. 2003;55:379–87.CrossRef
12.
go back to reference Tas F. The contribution of countries and world regions in productivity of oncological publication. Ann Oncol. 2008;19:1962–8.CrossRefPubMed Tas F. The contribution of countries and world regions in productivity of oncological publication. Ann Oncol. 2008;19:1962–8.CrossRefPubMed
Metadata
Title
An analysis of the most-cited research papers on oncology: which journals have they been published in?
Author
Faruk Tas
Publication date
01-05-2014
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 5/2014
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-1608-7

Other articles of this Issue 5/2014

Tumor Biology 5/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine